FDA Clears AI Triage Tool to Detect Additional Findings on CT Scans
The U.S. Food and Drug Administration has granted clearance to an artificial intelligence triage tool designed to assist radiologists by detecting up to ten additional findings on computed tomography (CT) scans.
The system works by automatically flagging specific abnormalities in CT images, allowing radiologists to prioritize their workflow and potentially catch conditions that might otherwise be missed during initial review. Such tools are increasingly viewed as a way to reduce diagnostic errors and improve efficiency in medical imaging departments that face high workloads.
AI-assisted radiology triage has been an area of growing interest, with multiple companies developing algorithms to support clinicians in detecting conditions ranging from intracranial hemorrhages to lung nodules. The regulatory pathway for such software typically requires validation studies demonstrating acceptable performance across diverse patient populations and imaging equipment.
The clearance reflects continued FDA engagement with AI-based medical devices, which have seen accelerated authorization timelines in recent years under programs intended to bring innovative healthcare technologies to market more efficiently.